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ABSTRACT 
 
 Wilson’s disease is a rare genetic disease that can present very early in life as 
a clinically non-specific illness with abnormal biochemical tests to life-threatening 
cirrhosis, liver failure and irreversible neurological deficits. Diagnosis can be 
challenging if symptoms are minimal. Wilson’s disease can range from a relatively 
mild disease if strict adherence to medications is maintained to a very difficult 
disease that requires liver transplantation as the only option for a normal life. I have 
analyzed the cases of three patients.  Patient 1 initially presented with hepatic lesions 
at age sixteen. This was the first step in clinical workup that eventually led to his 
diagnosis of Wilson’s disease. He has had a difficult course and has recently been 
placed on the liver transplantation list. Patient 2 presented with deranged liver 
transaminases, decreased serum copper and decreased ceruloplasmin while 
hospitalized with mononucleosis at the age of 10.  Patient 3 is the older sister of 
patient 2. At age seventeen, she presented with fatigue, leg swelling and absence of 
menstruation for five months at the time of initial hospitalization. 
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INTRODUCTION 
 
 Wilson’s disease is a rare autosomal recessive genetic disease that results in 
ineffective metabolism of copper. Copper is an essential trace metal in the human 
body that acts as a cofactor and permits electron transfer in many endogenous 
metabolic reactions (4). The liver is the central organ involved in copper metabolism 
and homeostasis. It has an exceptional capacity for storage and excretion of this 
metal. Wilson’s disease is caused by a mutation in the ATP7B gene on chromosome 
13 responsible for coding a copper-transporting p-type ATPase enzyme (7). There 
are over three hundred mutations of Wilson’s ATPase and H1069q is the most 
common. Not all identified mutations necessarily lead to this metabolic illness, 
however. The ATPase is responsible for copper transport within the hepatocyte and 
incorporating copper into ceruloplasmin—the major copper carrying glycoprotein 
synthesized by the liver. The overwhelming majority of ceruloplasmin is found in the 
plasma.  Mutations to ATP7B causes a decrease in both copper excreted through the 
biliary system and the quantity of copper bound to ceruloplasmin. The end result is 
copper accumulation in many different tissues such as the liver, central nervous 
system, cornea, and kidneys (5). Clinical signs and symptoms are relative to these 
locations and they include for example: hepatomegaly, acute hepatitis, movement 
disorders, seizures, depression, Kayser-Fleischer rings (copper deposits in 
Descemet’s membrane of the Cornea), nephrolithiasis, and musculoskeletal 
abnormalities. If clinical onset occurs in childhood, hepatic dysfunction is the most 
common presentation (2).  In an individual with excess copper in their system, there 
can be a rapid deterioration in hepatic function following a viral illness or other 
external factor that has triggered injury. With regards to hepatic dysfunction in a 
patient with Wilson’s disease, the Nazer et al prognostic classification was developed 
in order to assess the prognosis of a patient with Wilson’s disease based on three 
parameters of liver function: level of serum bilirubin, AST, and INR.  The objective is 
to identify patients who will probably not respond well to therapy and are at an 
increased risk of dying if liver transplantation is not performed. A score of greater 
than 7 suggests a risk of death if transplantation is not performed (Table 1) (6,9).  
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 In the general population, Wilson’s disease is found in 1/30 000 people and 
1/90 000 are carriers (4). Socio et al state that it is even more rare—occurring in 1/40 
000 people (9). Diagnosis is based on a combination of features such as clinical 
presentation, biochemical laboratory testing, and mutation analysis. No single 
diagnostic test can exclude or confirm Wilson’s disease with complete certainty. 
Parameters that can direct a medical team to a correct diagnosis include: A positive 
family history, Kayser-Fleischer rings, low ceruloplasmin level (<20mcg/dL), free 
copper >25mcg/dL, and 24hr urine copper >100mcg/24hr (9). Many patients don’t 
display these parameters in an undisputed way and this poses a challenge in 
achieving a prompt and definitive diagnosis. Patients may require genetic testing if 
necessary.  Either way, early detection is desirable in order to avoid dramatic disease 
progression (7).  The intent of treatment is to restore hepatic copper homeostasis by 
systemic chelation (7). The measurement of copper content is important to rule out 
other liver disorders such as autoimmune hepatitis, chronic hepatitis B and C, Alpha-
1 Antitrypsin deficiency, Rotor syndrome, Gilbert syndrome. The most widely used 
treatment for Wilson’s disease is Penicillamine. It is classified as an anti-copper drug 
or chelating agent. Penicillamine has been available longer than all anti-copper drugs 
(10). It does come with some serious side effects, however, such as toxicity, 
hypersensitivity reactions, activation of autoimmune diseases, and neurologic 
worsening, and is being replaced by other equally effective and less toxic drugs as 
stated by Brewer and Askari (2). Zinc is also very commonly used as effective 
treatment and/or maintenance therapy of Wilson’s disease. It works by inducing 
intestinal cell metallothionein and inhibits the absorption of copper (2,11). Other 
drugs include Trientene, which is a chelating agent, and Tetrathiomolybdate, which 
acts through a novel mechanism of action. It forms an unabsorbable tripartite 
complex with protein, copper, and itself, which will place the patient in a negative 
copper balance according to Bremner et al. (1,2).  Classically, Penicillamine has 
remained the first-line treatment of Wilson’s disease, however there is a growing shift 
towards selecting Zinc first instead (1).  If not treated sufficiently, Wilson’s disease 
can progress to liver failure and irreversible neurological deficits such as decreased 
cognition and gait ataxia before death. 
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CASE REPORTS 
 
Patient 1 
 Patient D.V. was born on September 25th, 1991 in his mother’s third 
regularly controlled pregnancy. He was first hospitalized at University Hospital Center 
Zagreb at the Department of Pediatric Gastroenterology as a 16 year old between 
June 20th-July 24th, 2007 for the purpose of diagnostic workup. He was initially sent 
from OB Bjelovar with the diagnosis of liver lesions of unknown etiology.  Other than 
an episode of bronchitis at the age of four and chicken pox later on, the patient had a 
clinically uneventful childhood. Physical and psychomotor development was 
described as normal and on time. The patient was regularly vaccinated and did not 
have any post-vaccination complications. For a couple of years prior to his initial 
hospitalization in OB Bjelovar, the patient suffered from occasional spasms of both 
hands, both forearms, and both thighs. Sometimes the spasms were caused by 
exertion and they lasted about 5 minutes, but they would pass spontaneously. The 
complaints initially appeared about once a week, but ten days prior to his 
hospitalization at OB Bjelovar they became more frequent and severe. The day 
before admission, he had thirty episodes of finger and hand spasms but he didn’t 
suffer from any while hospitalized.  
On initial physical examination, the patient presented with slight jaundice, 
icteric sclera, and his liver was palpable two centimeters below his right costal 
margin. Abdominal ultrasound revealed a mildly enlarged liver, and an extremely 
enlarged gall bladder (12x6cm) that lacked concretions and signs of inflammation. 
Ophthalmologic examination did not reveal Kayser-Fleischer rings. On biochemical 
testing, the patient had elevated transaminases (AST 127 U/L and ALT 151 U/L). 
Immunological testing involving the following antibodies: ANA, ANCA, LKM-1 were all 
negative. EBV Viral Capsid Antigen and EBV Nuclear Antigen were positive, which 
meant that the patient previously had mononucleosis. The patient’s coagulation tests 
were very poor. He had a PT activity percentage of 36% and his APPT was 49.6 
seconds—well above the normal range of 29-33 seconds.  He was also 
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thrombocytopenic. As a result, the patient received fresh frozen plasma multiple 
times throughout his hospitalization. The patient’s serum copper was 11.2µmol/L, his 
urine copper content was measured at 10.6 µmol/dU, and his ceruloplasmin was 
0.12g/L. A sample of dried hepatic tissue was found to have 1387.9 µg of copper per 
gram of tissue. 
During his stay, the patient had a 1.4cm in length sample of his liver undergo 
biopsy. Histologically, there was a strong disturbance in architecture and remodeling 
of liver parenchyma due to expansion and fibrosis of the portal passages and 
numerous portal septa. There was ductal proliferation with mononuclear cell infiltrate. 
Many hepatocytes were described as foamy and there was the occasional 
appearance of Mallory bodies. In some hepatocytes, macro- and microsteatosis was 
found. Copper was found only in trace amounts.  There was extensive fibrosis that 
was worrisome.  The pathologist suggested that these findings were consistent with 
what could be expected in a patient with Wilson’s disease. Based on all the findings 
over the course of his hospitalization, the patient was diagnosed with Wilson's 
disease and therapy was initiated. His initial regimen was Metalcaptase 
(Penicillamine) 300mg 2+1+1 either half an hour before a meal or two hours after and 
vitamin B6. He was also told to avoid foods rich in copper such as shellfish, 
chocolate. 
On August, 3rd, 2007 the patient visited the outpatient clinic ten days after 
returning home from his initial and extensive five week hospitalization. At the time, 
three weeks had passed since chelating therapy was initiated. The patient reported 
no nosebleeds, he was not jaundiced, but his sclera were still mildly icteric. On 
physical examination there was no organomegaly. Biochemical tests revealed 
elevated transaminases (AST 149U/L and ALT 136 U/L), elevated bilirubin (77 µmol), 
and coagulation issues. PT activity percentage was 33%, APPT was 53.5s, and he 
had platelet count of 120x10^9/L. 
Two weeks later on August 17th, 2007, the patient once again visited the 
outpatient clinic. It was noted that he was not healing as desired based on his 
coagulation tests despite regularly taking his prescribed medications. On physical 
examination, the patient was jaundiced and his liver was palpable below the right 
costal margin.  He did not have edema, petechiae, angiomas, nor xantomas.  
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Between August 23rd and October 26th, 2007, the patient was hospitalized for 
the second time. Initially, prominent urination of copper was achieved but there was 
unsatisfactory correction of the PT so he was often transfused with fresh frozen 
plasma. Two days before his arrival, the patient developed swelling in his lower 
extremities and notable weight gain.  He was jaundiced, he had very prominent veins 
on his anterior trunk due to ascites, he had angiomas around his umbilicus and his 
liver was palpable two centimeters below his right costal margin. During his stay, he 
immediately received replacement of albumin and was given diuretics. Dosage of 
Metalcaptase was raised too, which resulted in transient leucopenia. After ten days, 
the patient lost 13kg of weight, his jaundice faded, but his notable coagulation 
defects persisted. The patient’s Nazer score correlated with a good prognosis and 
that conservative treatment with medication was sufficient. On the 21st day of 
hospitalization, he was given Zinc Acetate (50mg TID) to complement the chelating 
effects of Penicillamine. By the second month, the PT was finally satisfactory and he 
received no fresh frozen plasma in his final twenty days of hospitalization. By the end 
of the patient’s hospitalization, it was noted that his most chronic problem was his 
slow functional healing and return of hepatic function—relative to his PT value. It was 
concluded that combined chelating therapy with Zinc Acetate and Metalcaptase was 
the best way to move forwards towards clinically stability. 500mg 3x3 daily of KCl and 
1g of CaCO3 were also added in his treatment regimen. 
The patient’s third hospitalization occurred between September 11th to 23rd, 
2007. He described subjectively feeling well despite being febrile, sleepy, and feeling 
pain in his throat. On the basis of imaging, biochemical lab results, and the patient’s 
physical examination, which notably presented weakened breathing sounds on the 
right side of his lungs, it was concluded that the patient had an airway infection and 
subsequent right-sided basal pneumonia with effusion. Parenteral antibiotic therapy 
(Cefuroxime, a third-generation cephalosporin) was required for fourteen days. The 
patient also received multiple infusions of albumin because of hypoalbuminemia and 
displayed prompt improvement in labs and clinical status. Biochemical laboratory 
results also unexpectedly showed a low value of copper in urine and high copper in 
serum despite regular therapy. 
The patient had two separate visits as an outpatient, one week apart, on 
November 30th, 2007 and December 7th, 2007. He did not look icteric however and 
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he had his best PT activity percentage (45%) until that point in time. Liver function 
tests remained elevated. Copper in serum was measured at 7.4µmol/L and urine 
copper content was 16 mmol/dU. Chest x-ray examination showed complete 
restitution of his lung fields relative to his hospitalization two months prior. 
The patient was admitted for his fourth hospitalization between March 26th, 
2008 and April 15th 2008. On the day of admittance, the patient reported pain in his 
left knee and neck. The patient initially went to visit OB Pakrac where he was 
thoroughly examined, rehydrated, and received antibiotic therapy (1g of Ceftriaxone) 
before being sent to KBC Zagreb. 
The patient was hypotensive, tachycardic, and febrile but had no jaundice. He 
also had a petechial rash. It was noted that the patient had dried blood in his 
posterior pharynx which suggested previous episodes of bleeding.  A rheumatologist 
was consulted and concluded that the patient, based on anamnesis and lab results, 
most likely had reactive arthritis— but a complication of Wilson’s disease could not 
be ruled out. The patient continued Ceftriaxone for another two weeks, received fresh 
frozen plasma three times for his coagulation defects, and was given 1.2g of 
Ibuprofen daily for his arthritis. Due to constant venepuncture and weak regeneration 
red blood cells, the patient developed anemia, which was worrisome. 100mg of Iron 
was added to his daily treatment regimen. It was concluded that the patient suffered 
an acute episode of gastroenterocolitis that destabilized his main illness. This 
showed that his liver does not have the reserves in the case of increased demand. 
 On September 5th, 2008, iron supplementation was removed from therapy. 
On November 7th, 2008 the patient started receiving Aldactone 2x40mg for an 
unspecified reason. Lab results showed that his serum copper concentration was 3.6 
µmol/L and urine copper concentration of  17.26 µmols/dU 
 On February 12th, 2012, dosage of Aldactone was raised to one 100mg tablet 
daily. 
D.V. was hospitalized for the fifth time October 12th to 15th, 2010 for extensive 
follow-up. After his visit in the outpatient clinic on November 7th, 2008, the patient 
visited the outpatient clinic another six times prior to this hospitalization. Throughout 
these visits, elevated liver function enzymes and coagulation defects remained. Also 
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in the meantime, the patient developed spider nevi on his forearms, hands and neck, 
diffuse hypopigmented changes developed between his scapulas, his dose of 
Aldactone was lowered to 100mg daily, and his older brother had his urine tested for 
copper content which resulted within normal range.  
During this visit, the patient was consulted by an ophthalmologist and a 
neurologist and nothing remarkable was noted by either. It was recommended to do 
thyroid hormone status. Ultrasound of the abdomen revealed a normal sized liver, 
biliary tract, and pancreas without visible focal lesions. Once again, the patients 
coagulation tests were poor—especially his platelet count which was 88x10^9cells/L. 
AST and ALT were also both elevated at 56 U/L and 108 U/L respectively. It was 
concluded at the end of this hospitalization that the patient’s status was stable. Due 
to age, the patient would now continue to be followed by an adult gastroenterologist 
and specialist of hepatalogy, Dr. Mirjana Kalauz. 
At the outpatient clinic on November 3rd, 2011, thyroid hormones came back 
normal normal.  The patient would have two more unremarkable outpatient visits in 
the next year. For unspecified reasons, Zinc Acetate and Aldactone were removed 
from therapy. 
In November 2012, the patient was hospitalized in OB Pakrac because of 
suspicion of appendicitis. The patient felt pain in his abdomen, initially at the top of 
his abdomen then diffuse then localized iliocecal, febrile without diarrhea. With 
conservative treatment, his pain subsided and he wasn’t operated.  
The patient arrived on January 17th, 2013 for a one-day scheduled 
hospitalization. Abdominal ultrasound was unremarkable.  For the first time the 
patient underwent an upper endoscopy. The patient’s esophagus revealed visible 
first degree varices, without redness. The stomach was normally positioned but had 
mucosal erosions and subcardial varicosities.  The patient needed further follow-up to 
analyze the patient’s portal circulation system. The patient continues to have poor 
coagulation tests. There was 8.43 µmol/dU of copper found in the urine. PT activity 
percentage was 43% and thrombocytes were measured to be a low 55x10^9/L.. 
Transaminases were elevated (AST 64 U/L and ALT 67 U/L) and the patient’s direct 
bilirubin concentration was slightly elevated at 54 µmol/L. It was noted that the 
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patient had a six month old daughter and that it is recommended to do molecular 
analysis of her DNA once she reaches the age of two. 
The patient was once again hospitalized between April 10th to 16th, 2013, at 
University Hospital Center Zagreb for extensive workup to evaluate the current state 
of his illness and to also assess his portal circulation due to esophageal and 
subcardial varices that were discovered three months prior. A contrast MSCT of the 
abdomen performed showed that the patient’s liver had a prominent lobular contour 
that looked cirrhotic. Focal lesions were lacking, however. The gallbladder was 
distended due to a high quantity of bile but there were no signs of inorganic lithiasis. 
Arterial blood supply of the liver was typical. Portosystemic collaterals were present. 
Morphologically a normal pancreas was found. Multiple enlarged lymph nodes were 
also found locally and also in the retroperitoneum. Kidneys and adrenal glands were 
normal—with no dilation of the kidney canal system. Colonoscopy revealed external 
hemorrhoids. Finally, abdominal x-ray of the small intestinal tract showed completely 
normal passage.  
The laboratory results today showed elevated liver transaminases (AST 78 
U/L and ALT 79 U/L), elevated direct bilirubin (71 µmol/L), severe thrombocytopenia 
(44x10^9/L) and serum copper was 10.1µmol/L. 
The patient was prescribed Propranolol 20mg BID to conservatively begin 
treatment of his varices.  
The patient was hospitalized at KBC Zagreb on September 25th, 2013—his 
twenty-second birthday for re-evaluation of his illness. Abdominal ultrasound was 
unremarkable. 
Upper endoscopy showed a normally dilated esophagus with varices in a 
chain-like formation down the middle third. The stomach was in normal position and 
there was normal peristalsis that followed down to the pylorus. Hyperemia with 
multiple chronic erosions was noted at the junction of the antrum and pylorus. It was 
described that the patient had newly found elements of progressive liver cirrhosis, 
splenomegaly, and lowered coagulation function. On his next hospitalization it was 
asked to perform: routine labs plus ceruloplasmin, copper in serum, 24h copper in 
urine, beta2 microglobulin, PET scan of the patient’s periportal lymph nodes, MR 
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angiography, EUS with imaging of periportal lymphadenopathy, examination by 
hepatologist, evaluation if liver transplant is required. 
 Once again liver function tests showed elevated transaminases (AST 63 U/L 
and ALT 68 U/L) and prolonged APPT (40.3s). The patient’s platelet count was at it’s 
lowest ever (38x10^9 cells/L). Serum copper was 9.5 µmol/L and 12.35 µmol/dU of 
copper content in urine. The patient was given furosemide 40mg. 
 The patient was hospitalized on February 19th, 2014 for re-evaluation of his 
disease state. For one month prior, he described an 'accumulation of water' in his 
body and that his shins and hands bothered him the most in particular. He stated that 
his is often fatigued. 100mg of Aldactone was reintroduced as therapy combined with 
Furosemide. On physical examination, it was noted that the patient had ascites, 
swollen feet and ankles, mildly jaundiced skin, icteric sclera, and 
hepatosplenomegaly. He also has decreased walking coordination. On mental 
examination, patient is slow to respond in conversation. It was concluded that patient 
D.V. urgently required a liver transplantation due to decompensated liver cirrhosis. 
 
Patient 2 
Patient I.B. was born in her mother’s fourth uneventful pregnancy on March 
8th, 2002. At birth she weighed 4000g. She was breastfed for her first six months of 
life and vaccinated regularly. Beginning in November 2012, she complained of having 
a burning sensation in her throat and a fever only lasting one day. She was given 
Klavocin (Amoxicillin-Klavulanic Acid) but upon first dose she developed urticaria and 
therapy was discontinued.  Two days later, laboratory results showed elevated liver 
enzymes and she was sent to the clinic of infectious diseases in Mostar for clinical 
workup where she was ultimately diagnosed with mononucleosis. Here, it was also 
proven that she had decreased serum copper and ceruloplasmin values (no 
documentation).  
The patient was referred to and admitted to KBC Zagreb at the Department of 
Pediatric Gastroenterology for the first time between April 2nd -17th, 2013 under the 
suspicion of having Wilson’s disease.  A 2.5cm biopsy sample of hepatic tissue taken 
for analysis. The tissue was described as having disordered architecture, moderate 
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inflammatory infiltrate, and some peripheral portal fields displayed piecemeal 
necrosis.  Neither Prussian Blue, PAS, and Rhodanine dye showed positive staining 
for hemosiderin, iron, nor copper in the cytoplasm of the hepatocytes. The 
pathologist stated that although copper deposits were not identified, the diagnosis of 
Wilson’s disease could not be excluded. Analysis of dry liver tissue showed 864.5µg 
of copper per gram of dry tissue however. Toxicology analysis proved that iron was 
within normal range. Genetic analysis of the patient's DNA did not prove the most 
common H1069Q mutation.  An abdominal ultrasound that was performed described 
her liver and spleen as slightly enlarged. Serology for hepatitis B and hepatitis C 
were negative, however she was positive for EBV VCA IgG that would support her 
previous diagnosis of having mononucleosis. She was also positive for CMV IgG. 
Furthermore, detection for the selected antibodies:  ANA, ANCA, LKM1 were all 
negative thus narrowing the differential diagnosis. Ophthalmologic examination was 
unremarkable. It did not show pathognomic Kayser-Fleischer rings. Pediatric 
neurologist examination noted a discrete tremor in the patient’s fingers. EEG was 
normal.  
The patient, however, did have liver function test derangements such as 
raised transaminases (AST 163 U/L and ALT 352 U/L.) Coagulation tests were 
normal. Her copper in urine was measured at 2.18 µmol/L, her urine copper after 
penicillamine challenge was 17.64µmol/L. On the basis of her copper levels in urine 
pre- and post-penicillamine challenge test, her dry tissue liver biopsy, and the 
abundance of copper in her dry liver tissue, it was concluded that the patient has 
Wilson’s disease. As initial treatment, the patient was sent home with Penicillamine 
300mg TID and told to avoid foods with high copper content.  
 
Patient 3 
Patient D.B. was born in her mother's third uneventful pregnancy on February 
4th, 1996.  She had normal psychomotor development and was regularly vaccinated.  
She had had menarche at the age of thirteen. Her first hospitalization at University 
Hospital Center Zagreb was between May 20th-May 24th, 2013.  In the spring of 2013, 
her younger sister I.B. was diagnosed with Wilson’s disease. At the time of her 
sister’s diagnosis, doctors in Zagreb arranged with the father of the two girls to 
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perform lab screening on all members of I.B.’s immediate family members back home 
in Mostar, Bosnia.  
The patient was at the time of her first hospitalization in the third year of high 
school and actively playing volleyball for the first league team. In April 2013, she 
described feeling tired she has felt tired and for two straight weeks her legs would 
swell at any time of day. She stated that she had not menstruated since January 
2013.  
She had a percutaneous biopsy of the liver performed whilst under mild 
sedation with 5mg Midazolam IV without any side effects. She received some fresh 
frozen plasma before this procedure. Samples from her biopsy showed enlarged and 
moderately polymorphic hepatocytes with an abundance of inflammatory infiltrates 
such as lymphocytes, histiocytes, plasma cells, and a few eosinophils (councilman 
bodies between  Ductal proliferation was very prominent. Mallory inclusion bodies 
were identified within the cytoplasm. Peripheral portal fields  showed piecemeal 
necrosis. Perisinusioidal and pericellular fibrosis was very prominent. Histochemical 
staining with Prussian Blue dye for hemosiderin and Rhodanine for copper were 
negative. The pathologist concluded that there was mildly active cirrhosis of the liver. 
A differential diagnosis of Autoimmune Hepatitis, toxic damage to liver parenchyma, 
and Wilson’s Disease was suggested. In a separate dry tissue sample of the patients 
liver, 711.2 µg/g of dry weight tissue. 
Biochemical laboratory tests showed raised transaminases (AST 136 U/L and 
ALT 118 U/L). Coagulation tests showed PT activity percentage to be 40%, and a 
41.3s APPT. Her copper in urine was measured at 14.52 µmol/dU and after 
Penicillamine challenge it was 15.65µmol/dU. Her albumin was only 28.5 g/L which is 
below reference range. 
 Based on all these results, it was concluded that D.B., like her younger sister, 
had Wilson’s disease which was discovered in an early hepatic insufficiency phase. 
As initial treatmeant, she was given Penicillamine 300mg 2 + 1 + 2 tablets which she 
was advised to take two hours after her meals and 50mg of vitamin B6 daily. 
At her second hospitalization between June 14th to 19th, 2013, it was 
determined that D.B. did not have the most common H1069Q (exon 14) mutation of 
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ATP7B that we would expect in the Eastern European region.  She didn’t gain any 
weight since her previous hospitalization but continued to have ankle swelling.  She 
had a head MRI performed in the area of her basal ganglia but imaging came back 
normal. The patient’s hepatic functional capacity is still poor as evidenced by her 
42.6s APPT and low 28.5 g/L of albumin. Her 24hr urine copper content was a very 
elevated 82.42 µmol/dU 
It was noted that it was important to exclude presumptions of neurological 
disease. The MRI of her basal ganglia, as noted above, was encouraging. As of now 
it appears that only the hepatic and gonadal diseases have been effected. It was 
suggested that the patient abstain from all physical activity for the time being. 
On July 15th, 2013 the patient was hospitalized again as part of a scheduled 
work-up of her illness. She continued to complain about ankle edemas around any 
time of the day.  
Her transaminases were elevated (AST 97 U/L and ALT 101 U/L). Her urine 
copper content was 43.24 µmol/dU 
 On September 2nd, 2013, the patient stated that she hasn’t had ankle swelling 
for the previous month. She had biochemical improvements with faster APPT, 
reduced liver transaminases (AST 64 U/L and ALT 59 U/L).  She was advised to be 
careful with her intensity of exercise. 
 The patient was hospitalized for three days between December 16th-19th, 
2013. The patient noted just mild ankle edema on a few occasions  within the past 
few months. 
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DISCUSSION 
 
  It is evident that Wilson’s disease can present with a varying degree of 
symptoms. It is one of the more rare causes of liver diseases in children and typically 
presents in the second decade of life (7). In the patients I observed, all three 
presented differently. One presented with hepatic lesions, another presented with 
fatigue, ankle swelling and lack of menstruation for five months and the third was 
found to have incidental lab findings that could indicate presence of Wilson’s disease 
as part of workup for a separate illness. At time of diagnosis, the average age of all 
patients studied was fourteen years and nine months. Patient 1 had the most 
extensive amount of history to analyze.  He was the only one of three patients to 
have all three parameters of “classic presentation”: hepatic, neurologic, and 
ophthalmologic involvement as described by Socio et al.– although they didn’t occur 
simultaneously (7). Throughout his entire illness, he had a deteriorating trend of 
health status and is now awaiting a liver transplant due to chronic cirrhosis and portal 
hypertension six and a half years after his initial diagnosis. The patient’s persistent 
liver damage is evidenced by elevated ALT values consistently over the upper limit of 
normal throughout his history (Figure 1).   This downward trend can also be seen in 
some of his lab parameters, for example, his thrombocyte count (Figure 3).  During 
his latest hospitalization, the patient was described as have mental delay in 
conversation and decreased coordination when walking. The question of whether or 
not he had been placed on the waiting list for liver transplant too late must be posed. 
Would it have been more beneficial to give him a new liver at an earlier point in time 
than allow his illness to progress to his central nervous system as much as it has?  In 
this particular case, as a representative of other cases with similar presentations and 
histories like this one, the resounding answer is yes.  Furthermore, patient 1 had a 
poor transition between pediatric care to adult care and as a result his health took a 
turn for the worse. Focused continuity of care is of high priority in patients with 
Wilson’s disease and must be addressed by a multidisciplinary team through active 
communication. As of now, patient 2 and patient 3 have had liver biopsies performed 
that showed extensive hepatocellular damage. They should both be carefully 
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monitored for the next year and if there is no clinical or biochemical improvements, 
additional medical therapy or liver transplantation should be considered. If additional 
medical treatment was selected, re-evaluation should be repeated after six months. 
Patient 2 and patient 3 also have never had a Nazer et al prognostic score evaluated.  
Since it is so simple, I recommend calculating it at every hospitalization for a patient 
with Wilson’s disease. It is necessary to always evaluate the liver for possible 
deterioration of function.  
 	   	  	  	  	  	  
 
Currently, patient 2 and patient 3, who are sisters, are taking their medications 
regularly and are clinically stable. Patient 3 also had an MRI of her head performed 
that was concluded to be unremarkable. It is important to track status of brain 
involvement in patients with Wilson’s disease because it is critical to avoid debilitating 
central nervous system involvement that presents with poor cognition and ataxia for 
example. If there is a patient with psychiatric symptoms with another clinical feature 
of probable Wilson’s disease, a complete workup must be done. What is also 
concerning about Patient 3, however, is that she did not menstruate for close to a 
year but that has recently returned to normal which is a very encouraging clinical 
improvement. Gonadal dysfunction is a serious consequence of Wilson’s disease. 
When you see a patient with delayed puberty in addition to at least one other clinical 
feature of probable Wilson’s disease, once again, a complete workup is suggested. 
With regards to gonadal dysfunction in a patient with Wilson’s disease, there is 
	   BILIRUBIN	  (mg/dL)	   AST	  (IU/L)	   INR	  0	   <5.8	   <100	   <1.3	  1	   5.9-­‐8.8	   100-­‐150	   1.3-­‐1.6	  2	   8.9-­‐11.7	   151-­‐200	   1.6-­‐1.9	  3	   11.8-­‐17.5	   201-­‐300	   1.9-­‐2.4	  4	   >17.5	   >301	   >2.4	  
Table 1 Nazer et al (6) prognostic classification based on liver function. 
Score >7 suggests  a risk of death if liver transplantation not performed. 	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accumulating evidence that switching to Zinc may correct menstrual abnormalities 
better (12). 
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Figure 1. Observed concentration of ALT in Patient 1 between the years 2007-
2013. Abbreviation: UL, upper limit 	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Figure 2. Observed concentrations of thrombocytes in Patient 1 between the 
years 2007-2013. Abbreviation: LL, lower limit 	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CONCLUSION 
 
 The presentation of Wilson’s disease in children is highly variable. This can 
make establishing a definitive diagnosis challenging if these symptoms are minimal. 
Furthermore, no single diagnostic test can exclude or confirm Wilson’s disease with 
complete certainty. If a patient has a confirmed diagnosis of Wilson’s disease, strict 
adherence to medical treatment, whether given Penicillamine or Zinc initially, and a 
low-copper diet is strongly advised to avoid dire clinical manifestations such as 
progressive hepatic failure or irreversible neurological deficits. It is also critical to 
promptly recognize unrelated febrile illness in a patient with Wilson’s disease. In such 
cases, the liver can be exhausted to the point of irreversible damage.  It is also 
suggested to do a Nazer et al prognostic score as often as possible to track the 
snapshot status of the patient’s liver functions and analyze trends over time. Wilson’s 
disease can be unnecessarily devastating if not treated promptly and efficiently 
therefore the consequences of poor disease control must be at the forefront of the 
medical team—especially if treating a young, maturing child or adolescent with many 
quality years of life ahead. 
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